FindTrial
Sign In

Pharmacotherapy for Schizophrenic Drug Users - 6

Pharmacotherapy for Schizophrenic Drug Users

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000281
Enrollment
0
Registered
1999-09-21
Start date
1994-09-30
Completion date
1999-08-31
Last updated
2016-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders, Shcizophrenia, Substance-Related Disorders

Keywords

anti psychotic agents

Brief summary

The purpose of this study is to evaluate maintenance neuroleptics for Schizophrenic patients who are cocaine abusers.

Interventions

BEHAVIORALAmantadine

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
VA Connecticut Healthcare System
CollaboratorFED
Yale University
Lead SponsorOTHER

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

Please contact site for information.

Design outcomes

Primary

MeasureTime frame
Drug use—
Retention—
Psychological symptoms—
Schizophrenic symptoms—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026